These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


143 related items for PubMed ID: 368044

  • 21. On the problems of switching from intravenous to oral administration in drug treatment of endogenous depression--a placebo-controlled double-blind trial with doxepin.
    Adler L, Hajak G, Lehmann K, Kunert HJ, Hoffmann G, Issinger J, Böke J, Huether G, Rüther E.
    Pharmacopsychiatry; 1997 Mar; 30(2):62-9. PubMed ID: 9131726
    [Abstract] [Full Text] [Related]

  • 22. A double-blind comparative trial of doxepin hydrochloride and chlordiazepoxide in anxiety and depression in general practice.
    Montgomery BA, Cullinan TR, Bayley AJ.
    Br J Clin Pract; 1970 May; 24(5):207-9. PubMed ID: 4916190
    [No Abstract] [Full Text] [Related]

  • 23. A comparative evaluation of doxepin and chlordiazepoxide in the treatment of psychoneurotic outpatients.
    Sterlin C, Ban TA, Lehmann HE, Jarrold L.
    Curr Ther Res Clin Exp; 1970 Apr; 12(4):195-200. PubMed ID: 4985940
    [No Abstract] [Full Text] [Related]

  • 24. Doxepin in the treatment of psychoneurotic patients.
    Beaubien J, Ban TA, Lehman HE, Jarrold L.
    Curr Ther Res Clin Exp; 1970 Apr; 12(4):192-4. PubMed ID: 4985939
    [No Abstract] [Full Text] [Related]

  • 25. A study with Sinequan (Doxepin).
    Koknel O, Eper O.
    Dis Nerv Syst; 1971 Jun; 32(6):405-8. PubMed ID: 5570694
    [No Abstract] [Full Text] [Related]

  • 26. Early onset of response to doxepin treatment.
    Barranco SF, Thrash ML, Hackett E, Frey J, Ward J, Norris E.
    J Clin Psychiatry; 1979 Jun; 40(6):265-9. PubMed ID: 376498
    [No Abstract] [Full Text] [Related]

  • 27. [Clinical experience with impavido in treatment of endogenous depressive conditions (author's transl)].
    Náhunek K, Cesková E, Svestka J.
    Cesk Psychiatr; 1977 Aug; 73(4):226-33. PubMed ID: 336226
    [No Abstract] [Full Text] [Related]

  • 28. Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression.
    Dunner DL, Cohn JB, Walshe T, Cohn CK, Feighner JP, Fieve RR, Halikas JP, Hartford JT, Hearst ED, Settle EC.
    J Clin Psychiatry; 1992 Feb; 53 Suppl():57-60. PubMed ID: 1531827
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Alprazolam treatment of postcoronary bypass anxiety and depression.
    Freeman AM, Fleece L, Folks DG, Sokol RS, Hall KR, Pacifico AD, McGiffin DC, Kirklin JK, Zorn GL, Karp RB.
    J Clin Psychopharmacol; 1986 Feb; 6(1):39-41. PubMed ID: 2869060
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Trial of a new psychotropic drug doxepin.
    Lang WR.
    N Z Med J; 1970 Sep; 72(460):184-8. PubMed ID: 5273564
    [No Abstract] [Full Text] [Related]

  • 38. Early phase-II semi double-blind study of the new alkaline propanolamine derivative enciprazine (short communication).
    Linden M, Helmchen H, Müller-Oerlinghausen B.
    Arzneimittelforschung; 1988 Jun; 38(6):814-6. PubMed ID: 3178922
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features.
    Tollefson GD, Holman SL, Sayler ME, Potvin JH.
    J Clin Psychiatry; 1994 Feb; 55(2):50-9. PubMed ID: 8077155
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.